Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1150 ARTÍCULOS , VIENDO DEL 631 AL 645

[Ethics and neuropsychological assessment]

Thomas-Antérion C, Barbeau E.

Geriatr Psychol Neuropsychiatr Vieil. 2012 Dec;10(4):445-52. doi: 10.1684/pnv.2012.0372.

[Effects of telmisartan on the level of Aβ1-42, interleukin-1β, tumor necrosis factor α and cognition in hypertensive patients with Alzheimer's disease]

Li W, Zhang JW, Lu F, Ma MM, Wang JQ, Suo AQ, Bai YY, Liu HQ.

Zhonghua Yi Xue Za Zhi. 2012 Oct 23;92(39):2743-6.

[MRI and PET in Alzheimer's disease]

Matsunari I.

No Shinkei Geka. 2012 Dec;40(12):1051-63.

The antipsychotic discontinuation in Alzheimer disease trial: clinical rationale and study design

Devanand DP, Mintzer J, Schultz S, Sultzer D, de la Pena D, Gupta S, Colon S, Schimming C, Pelton GH, Andrews H, Levin B.

Am J Geriatr Psychiatry. 2012 Apr;20(4):362-73. doi: 10.1097/JGP.0b013e3182110563.

Dogs with cognitive dysfunction syndrome: a natural model of Alzheimer's disease

Bosch MN, Pugliese M, Gimeno-Bayón J, Rodríguez MJ, Mahy N.

Curr Alzheimer Res. 2012 Mar;9(3):298-314. doi: 10.2174/156720512800107546.

Diabetes mellitus as a modulator of functional impairment and decline in Alzheimer's disease. The Real.FR cohort

Sanz CM, Hanaire H, Vellas BJ, Sinclair AJ, Andrieu S; REAL.FR Study Group.

Diabet Med. 2012 Apr;29(4):541-8. doi: 10.1111/j.1464-5491.2011.03445.x.

Using mental imagery to improve memory in patients with Alzheimer disease: trouble generating or remembering the mind's eye?

Hussey EP, Smolinsky JG, Piryatinsky I, Budson AE, Ally BA.

Alzheimer Dis Assoc Disord. 2012 Apr-Jun;26(2):124-34. doi: 10.1097/WAD.0b013e31822e0f73.

Bridging the pathophysiology of Alzheimer's disease with vascular pathology: the feed-back, the feed-forward, and oxidative stress

Polidori MC, Pientka L.

J Alzheimers Dis. 2012;28(1):1-9. doi: 10.3233/JAD-2011-111034.

Neuropsychological features of mild cognitive impairment and preclinical Alzheimer's disease

Salmon DP.

Curr Top Behav Neurosci. 2012;10:187-212. doi: 10.1007/7854_2011_171.

Does physical activity reduce risk for Alzheimer's disease through interaction with the stress neuroendocrine system?

Tortosa-Martínez J, Clow A.

Stress. 2012 May;15(3):243-61. doi: 10.3109/10253890.2011.629323. Epub 2012 Jan 4.

Variants in CYP17 and CYP19 cytochrome P450 genes are associated with onset of Alzheimer's disease in women with down syndrome

Chace C, Pang D, Weng C, Temkin A, Lax S, Silverman W, Zigman W, Ferin M, Lee JH, Tycko B, Schupf N.

J Alzheimers Dis. 2012;28(3):601-12. doi: 10.3233/JAD-2011-110860.

Effects of atorvastatin on cerebral blood flow in middle-aged adults at risk for Alzheimer's disease: a pilot study

Carlsson CM, Xu G, Wen Z, Barnet JH, Blazel HM, Chappell RJ, Stein JH, Asthana S, Sager MA, Alsop DC, Rowley HA, Fain SB, Johnson SC.

Curr Alzheimer Res. 2012 Oct;9(8):990-7. doi: 10.2174/156720512803251075.

Experiences of supporting people with Down syndrome and Alzheimer's disease in aged care and family environments

Carling-Jenkins R, Torr J, Iacono T, Bigby C.

J Intellect Dev Disabil. 2012 Mar;37(1):54-60. doi: 10.3109/13668250.2011.645473. Epub 2012 Jan 3.

Evidence for astrocytosis in prodromal Alzheimer disease provided by 11C-deuterium-L-deprenyl: a multitracer PET paradigm combining 11C-Pittsburgh compound B and 18F-FDG

Carter SF, Schöll M, Almkvist O, Wall A, Engler H, Långström B, Nordberg A.

J Nucl Med. 2012 Jan;53(1):37-46. doi: 10.2967/jnumed.110.087031.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias